Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Repithel

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
IntroductionInfection is a major threat to wound healing and a leading cause of graft loss in patients undergoing meshed skin… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
BackgroundAntiseptics are frequently used for the prophylaxis and treatment of local infections of chronic wounds. Whereas local… Expand
  • figure 2
  • table 1
  • table 2
Is this relevant?
2008
2008
A liposomal hydrogel with 3% povidone-iodine (PVP-ILH, Repithel) has shown clinical benefit in settings where inflammation and/or… Expand
Is this relevant?
2006
2006
The cytotoxicity of povidone-iodine in Repithel®, Betaisodona® ointment and Betaisodona® solution was investigated using CHO-K1… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2006
2006
BACKGROUND Moist wound treatment improves healing at a possibly increased risk of bacterial infection and many local antiseptics… Expand
Is this relevant?
2006
2006
The in vitro genotoxicity of povidone-iodine in Repithel®, Betaisodona® ointment and Betaisodona® solution was investigated using… Expand
  • table 1
Is this relevant?
2006
2006
UNLABELLED Moist wound treatment is a well recognized method for the treatment of aseptic acute and chronic wounds. While the… Expand
Is this relevant?
Review
2006
Review
2006
Background: Various standardized and/or validated models exist to test wound healing products. This article discusses their… Expand
  • table 1
Is this relevant?
2005
2005
Background: For moist wound treatment a new hydrogel-based agent containing povidone (PVP) iodine deposited in hydrosomes is now… Expand
Is this relevant?